Details

<p></p><p></p><p>Chapter 1&nbsp;&nbsp;&nbsp; </p>

<p>Infections in Transplantation: &nbsp;Introduction and Overview </p>

<p>Amar Safdar</p>

&nbsp;<p></p>

<p>Chapter 2 <b>&nbsp;&nbsp;&nbsp;&nbsp;</b></p>

<p>Infections in Heart, Lung, and Heart-Lung Transplantation</p>

<p>Andrés F. Henao-Martínez and José G. Montoya ^&nbsp;</p>

<p>^&nbsp;</p>

<p>Chapter 3<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Infections in Liver Transplantation</p>

<p>B. Sharmila Mohanraj, Amol S. Rangnekar, and Joseph G. Timpone, Jr</p>

<p>&nbsp;</p>

<p>Chapter 4<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Infections in Kidney and Pancreas Transplantation</p>

<p>Megan K. Morales, Matthew Cooper, Peter Abrams, and Joseph G. Timpone, Jr</p>

<p>&nbsp;</p>

<p>Chapter 5<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Infections in Intestinal and Multivisceral Transplantation</p>

<p>Raffaele Girlanda, Joseph G. Timpone, Jr, Kevin M. Soriano, and Thomas M. Fishbein</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>Chapter 6<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Infections in Limbs, Integuments, and Face Transplantation</p>

<p>Justin M. Broyles and Chad R. Gordon</p>

<p>&nbsp;</p>

Chapter 7<b>&nbsp;&nbsp;&nbsp; </b><p></p>

<p>Principles of Hematopoietic Stem Cell Transplantation</p>

<p>Michelle Limei Poon, Richard E. Champlin, and Partow Kebriaei</p>

<p>&nbsp;</p>

<p>Chapter 8<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Infections in Pediatric Transplant Recipients</p>

<p>Aspasia Katragkou,Lucy O’Connor, Emmanuel Roilides, and Thomas J. Walsh</p>

&nbsp;<p></p>

<p>Chapter 9<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Febrile Neutropenia in Transplant Recipients</p>

<p>Lior Nesherand Kenneth V. I. Rolston</p>

<p>&nbsp;</p>

<p>Chapter 10<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Cytopenias in Transplant Patients</p>

<p>Maura Barry, Sunandana Chandra, and Kenneth B. Hymes</p>

<p>&nbsp;</p>

<p>Chapter 11<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Infections in Allogeneic Stem Cell Transplantation</p>

<p>Marcus R. Pereira, Stephanie M. Pouch, and Brian Scully</p>

<p>&nbsp;</p>

<p>Chapter 12<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Complications Arising from Preparatory Conditioning Regimens for Stem Cell Transplantation </p>

Jasmine Zain and Merav Bar<p></p>

<p>&nbsp;</p>

<p>Chapter 13<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Intravascular Catheter and Implantable Device Infections in Transplant Patients</p>

<p>Nasia Safdar, Cybele Lara R. Abad, and Dennis G. Maki</p>

<p>&nbsp;</p>

<p>Chapter 14<b>&nbsp;&nbsp;&nbsp; </b></p>

Surgical Site Infections: Wound and Stump Infections<p></p>

<p>Nasia Safdar, Sara A. M. Zerbel, and Elizabeth Ann Misch</p>

<p>&nbsp;</p>

<p>Chapter 15<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Endovascular Infections and Endocarditis </p>

<p>Walter Zingg and Didier Pittet</p>

<p>&nbsp;</p>

<p>Chapter 16<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Gastrointestinal Infections and <i>Clostridium difficile </i>Infection</p>

<p>Stephen Harold and Herbert L. DuPont</p>

<p>&nbsp;</p>

<p>Chapter 17&nbsp;&nbsp;&nbsp; </p>

<p>Hepatobiliary Tract Infections</p>

<p>Jonathan Merola, Robert M. Mocharla, Alexander Z. Jow, Samuel H. Sigal, and Amar Safdar</p>

<p>&nbsp;</p>

<p>Chapter 18<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Ocular Infections in Transplant Patients</p>

<p>Ann-Marie Lobo,Lucia Sobrin,andMarlene L. Durand</p>

<p>&nbsp;</p>

Chapter 19<b>&nbsp;&nbsp;&nbsp; </b><p></p>

<p>Intracranial, Spinal, and Paraspinal Infections in the Transplant Recipient</p>

<p>Matthew W. McCarthy, Axel Rosengart and Thomas J. Walsh</p>

<p>&nbsp;</p>

<p>Chapter 20<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Respiratory Tract Infections: Sinusitis, Bronchitis, and Pneumonia </p>

<p>Benjamin A. Miko, Marcus R. Pereira, and Amar Safdar</p>

&nbsp;<p></p>

<p>Chapter 21<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Respiratory Tract Diseases That May Be Mistaken For Infection&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

Robert M. Kotloff, Burton F. Dickey, and Nicholas Vander Els<p></p>

<p>&nbsp;</p>

<p>Chapter 22<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Skin and Soft Tissue Infection in Transplant Recipients</p>

<p>Robert G. Micheletti and Carrie L. Kovarik</p>

<p>&nbsp;</p>

<p>Chapter 23<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Cutaneous Lesions that Mimic Infection in Transplant Patients </p>

<p>Ana Ciurea and Sharon Hymes</p>

<p>&nbsp;</p>

<p>Chapter 24<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Staphylococcus, Streptococcus, and Enterococcus </p>

<p>Amar Safdar and Donald Armstrong</p>

<p>&nbsp;</p>

<p>Chapter 25<b>&nbsp;&nbsp;&nbsp; </b></p>

<p><i>Enterobacteriaceae</i> in Transplantation</p>

<p>Kathryn Whitaker, Valerie Cluzet, and Emily A. Blumberg</p>

<p>&nbsp;</p>

<p>Chapter 26<b>&nbsp;&nbsp; </b></p>

<p>Pseudomonas, Stenotrophomonas, Acinetobacter, and Other Non-Fermentative Gram-Negative Bacteria & Medically Important Anaerobic Bacteria in Transplant Recipients </p>

<p>Kenneth V.I. Rolston and Amar Safdar</p>

<p>&nbsp;</p>

<p>Chapter 27<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Nocardiosis and Actinomycosis</p>

<p>Heather E. Clauss and Bennett Lorber</p>

<p>&nbsp;</p>

<p>Chapter 28<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Listeriosis</p>

<p>Heather E. Clauss and Bennett Lorber</p>

<p>&nbsp;</p>

<p>Chapter 29<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Tuberculosis </p>

<p>Cynthia Portal-Celhay and Jennifer A. Philips</p>

<p>&nbsp;</p>

<p>Chapter 30<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Nontuberculous Mycobacterial Disease in Transplant Recipients </p>

<p>Julie V. Philley, Amar Safdar, and Charles L. Daley </p>

<p>&nbsp;</p>

&nbsp;<p></p>

<p>&nbsp;</p>

<p>Chapter 31<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Invasive Fungal Disease in the Transplant Population: An Overview</p>

Jennifer L. Saullo,&nbsp; John R. Perfect, and Barbara D. Alexander<p></p>

<p>&nbsp;</p>

<p>Chapter 32<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Candida Infections in Hematopoietic and Solid Organ Transplant Recipients</p>

<p>Alison G. Freifeld and Carol A. Kauffman</p>

<p>&nbsp;</p>

<p>Chapter 33<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Aspergillosis</p>

<p>Michael J. Satlin, Samantha E. Jacobs, and Thomas J. Walsh</p>

<p>&nbsp;</p>

<p>Chapter 34&nbsp;&nbsp;&nbsp; </p>

<p>Mucormycosis </p>

<p>Brad Spellberg and Johan Maertens</p>

<p>&nbsp;</p>

<p>Chapter 35<b>&nbsp;&nbsp; </b></p>

<p>Cryptococcus Infections in Transplant Recipients</p>

<p>Raymund R. Razonable<b> </b>and<b> </b>Pearlie P. Chong</p>

<p>&nbsp;</p>

Chapter 36<b>&nbsp;&nbsp;&nbsp; </b><p></p>

<p>Histoplasmosis, Coccidioidomycosis and Diseases due to Other Endemic Fungi in Transplant Recipients</p>

<p>Pascalis Vergidis, Chadi A. Hage, and L. Joseph Wheat</p>

<p>&nbsp;</p>

<p>Chapter 37<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Cytomegalovirus </p>

<p>Amar Safdar and Donald Armstrong</p>

<p>&nbsp;</p>

<p>Chapter 38<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Epstein-Barr Virus Infection and Post-Transplant Lymphoproliferative Disease</p>

<p>Benjamin E. Gewurz, Amy Sievers, David M.Weinstock, Sheila Mitsuma and Amar Safdar </p>

<p>&nbsp;</p>

<p>Chapter 39<b>&nbsp;&nbsp;&nbsp; </b></p>

Herpes Simplex Viruses 1 and 2, Varicella Zoster Virus and Human Herpes Viruses 6, 7 and 8 in Transplant Recipients<p></p>

<p>Raymund R. Razonable*</p>

<p>&nbsp;</p>

<p>Chapter 40<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Respiratory Viral Infections in Transplant Recipients</p>

<p>Catherine Liu, Dora Y. Ho, and Michael Boeckh</p>

&nbsp;<p></p>

<p>Chapter 41<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Hepatitis A, B, C </p>

<p>Jonathan Merola, Alexander Z. Jow, and Samuel H. Sigal</p>

&nbsp;<p></p>

<p>Chapter 42<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Enterovirus Infection in Immunocompromised Hosts</p>

<p>Joanna Schaenman, Dora Y. Ho, Lindsey R. Baden, and Amar Safdar</p>

<p>&nbsp;</p>

<p>Chapter 43<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Parvovirus B19&nbsp; </p>

<p>Morgan Hakki and Lynne Strasfeld</p>

<p>&nbsp;</p>

<p>Chapter 44<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>West Nile Virus in Immunocompromised Hosts&nbsp; </p>

Dora Y. Ho, Joanna M.D. Schaenman, and Lindsey R. Baden <p></p>

<p>&nbsp;</p>

<p>Chapter 45<b>&nbsp;&nbsp;&nbsp; </b></p>

Rare and Emerging Viral Infections in the Transplant Population<p></p>

<p>Susanna K. Tan, Jesse J. Waggoner, and Stan Deresinski</p>

<p>&nbsp;</p>

<p>Chapter 46<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Parasitic Infections in Transplant Recipients: Toxoplasmosis, Strongyloidiasis and Other Parasites </p>

<p>Brian G. Blackburn and José G. Montoya</p>

<p>&nbsp;</p>

<p>Chapter 47&nbsp;&nbsp;&nbsp; </p>

<p>Impacts and Challenges of Advanced Diagnostic Assays for Transplant Infectious Diseases</p>

<p>N. Esther Babady,Yeon Joo Lee, Genovefa Papanicolaou,and Yi-Wei Tang</p>

<p>&nbsp;</p>

Chapter 48&nbsp;&nbsp;&nbsp; <p></p>

<p>Diagnosis of Systemic Fungal Diseases</p>

<p>Simon F. Dufresne, Kieren A. Marr and Shmuel Shoham</p>

<p>&nbsp;</p>

Chapter 49<b>&nbsp;&nbsp;&nbsp; </b><p></p>

<p>Viral Diagnostics </p>

<p>Robin K. Avery and Belinda Yen-Lieberman</p>

<p>&nbsp;</p>

Chapter 50<b>&nbsp;&nbsp;&nbsp; </b><p></p>

<p>Antibiotic Consideration in Transplant Recipients </p>

<p>Jerry Altshuler, Samuel L. Aitken, Melanie Maslow, John Papadopoulos, and Amar Safdar</p>

<p>&nbsp;</p>

<p>Chapter 51<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Pharmacokinetics and Pharmacodynamics of Antibiotics in Transplant Patients </p>

<p>Kelly E. Schoeppler, Scott W. Mueller, and Gerard R. Barber</p>

<p>&nbsp;</p>

<p>Chapter 52<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Antifungal Consideration for Transplant Recipients</p>

<p>Yanina Dubrovskaya, Man Yee Merl, David S. Perlin, and Amar Safdar</p>

<p>&nbsp;</p>

<p>Chapter 53<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Immunomodulatory Properties of Antifungal Agents on Immune Functions of the Host </p>

<p>Maria Simitsopoulou and Emmanuel Roilides</p>

<p>&nbsp;</p>

<p>Chapter 54<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Antiviral Consideration for Transplantation Including Drug Resistance</p>

<p>Sunwen Chou and Nell S. Lurain </p>

<p>&nbsp;</p>

<p>Chapter 55<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Pharmacokinetics and Pharmacodynamics of Antiviral Drugs in Special Population</p>

<p>Marco R. Scipione* and John Papadopoulos </p>

<p>&nbsp;</p>

<p>Chapter 56<b>&nbsp;&nbsp;&nbsp; </b></p>

Anti-Mycobacterial Consideration in Transplantation Including Drug Non-Susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease<p></p>

<p>Julie V. Philley and David E. Griffith </p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>Chapter 57<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Adaptive Immunotherapy for Opportunistic Infections</p>

<p>Aspasia Katragkou, Thomas J. Walsh, and Emmanuel Roilides&nbsp; </p>

<p><b>&nbsp;</b></p>

<p>Chapter 58<b>&nbsp;&nbsp;&nbsp; </b></p>

Immunotherapy for Invasive Mold Disease in Transplant Patients – Dendritic Cell Immunotherapy, Interferon-gamma, Recombinant Myeloid Growth Factors, and Healthy Donor Granulocyte Transfusions<p></p>

<p>William K. Decker, Matthew M. Halpert, Vanaja Konduri, Dan Liang, Christopher N. Hampton, and Amar Safdar</p>

<p>&nbsp;</p>

<p>Chapter 59<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Antimicrobial Stewardship: Considerations for a Transplant Center </p>

<p>Susan K. Seoand Graeme N. Forrest</p>

<p>&nbsp;</p>

Chapter 60<b>&nbsp;&nbsp;&nbsp; </b><p></p>

<p>The Use of Palliative Care in Organ Transplant Patients and End of Life Issues</p>

<p>Jenny S. Ayala and Joseph Lowy</p>

<p>&nbsp;</p>

<p>Chapter 61<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Infection Control Strategies in Transplant Populations</p>

<p>Scott Cutro, Michael Phillips, and Harold W. Horowitz</p>

&nbsp;<p></p>

<p>Chapter 62<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Travel and Transplantation&nbsp; </p>

<p>Camille Nelson Kotton and José G. Montoya</p>

<p>&nbsp;</p>

<p>Chapter 63<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Vaccination in Organ Transplant </p>

<p>Lara Danziger-Isakov and Camille Nelson Kotton</p>

<p>&nbsp;</p>

<p>Chapter 64<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Prevention of Fungal Disease</p>

<p>Shirish Huprikar and John R. Wingard</p>

<p>&nbsp;</p>

<p>Chapter 65<b>&nbsp;&nbsp;&nbsp; </b></p>

<p>Antimicrobial Drug Prophylaxis: Challenges and Controversies </p>

<p>Gaurav Trikha, Marcio Nucci,John R. Wingard and Amar Safdar</p><br><p></p><p></p>

<div><br></div><div><p>Amar Safdar, MD <br> Clinical Associate Professor of Medicine</p>

<p>Texas Tech University Health Sciences Center El Paso</p>

<p>Paul L. Foster School of Medicine</p>

<p>El Paso, TX, USA</p><br></div>

<p>This comprehensive volume provides a platform from which both major and minor infectious diseases related issues are addressed in-depth among this highly susceptible population.&nbsp; The book begins with an overview of infections in various modalities. This is followed by chapters on clinical disorders, etiologic agents, therapeutics, and infection prevention. Chapters include easy-to-follow figures and tables, radiologic images, and pictorial demonstrations of various disease states to familiarize and reacquaint the transplant clinicians and surgeons in practice and training, and those belonging to subspecialties providing supportive care for these patients. Discussions to enumerate the noninfectious causes that mimic infectious diseases; clinical relevance and effective utility of existing and emerging diagnostic tools are presented throughout the book. Authored by leaders in their fields, this book is the go-to reference for management of patients undergoing hematopoietic and solid organ transplantation.</p>

<p>Provides the major and minor infectious disease related issues in patients undergoing hematopoietic and solid organ transplantation</p><p>Comprehensive resource provides an overview and management strategies for clinical disorders, etiologic agents, therapeutics and prevention</p><p>Authored by leaders in the field</p>

US